Rivaroxaban: searching the integral vascular protection-Reference-Cited by-同舟云学术

Rivaroxaban: searching the integral vascular protection

Published:2018-07-03 Issue:7 Volume:11 Page:719-728
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Barrios Vivencio¹,Almendro-Delia Manuel²,Facila Lorenzo³,Garcia-Moll Xavier⁴,Mazón Pilar⁵,Camafort Miguel⁶,Cepeda José María⁷,Mediavilla Garcia Juan Diego⁸,Pose Reino Antonio⁹,Suarez Fernandez Carmen¹⁰

Affiliation:

1. Cardiology Department, Hospital Ramón y Cajal, Madrid, Spain

2. Cardiology Department, Hospital Virgen Macarena, Sevilla, Spain

3. Cardiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain

4. Cardiology Department, Hospital Sant Pau, Barcelona, Spain

5. Cardiology Department, Hospital Clinico Universitario de Santiago de Compostela. CIBERCV, Spain

6. Internal Medicine Department, Atrial fibrillation Unit UFA Hospital Clinic, Universitat de Barcelona, Barcelona, Spain

7. Internal Medicine Department, Hospital Vega Baja, Alicante, Spain

8. Internal Medicine Department, Hospital Universitario, Granada, Spain

9. Internal Medicine Department, Complexo Hospitalario Universitario de Santiago, Santiago, Spain

10. Internal Medicine Department, Hospital Universitario de la Princesa, Madrid, Spain

Funder

Bayer Hispania

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1495559

Reference67 articles.

1. European Society of Cardiology: Cardiovascular Disease Statistics 2017

2. Coronary heart disease epidemics: not all the same

3. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

4. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013

5. The epidemiological concept of residual risk

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach;Expert Review of Cardiovascular Therapy;2023-11-02

2. Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation;Expert Review of Cardiovascular Therapy;2023-11-02

3. The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-05

4. Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study;Journal of Clinical Medicine;2022-06-20

5. Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy;Current Cardiology Reviews;2021-05-21